OGG1 and Alzheimer disease: In addition, Iida et al. [9] used immunohistochemical methods to show that levels of the mitochondrial form of OGG1 were significantly decreased in the orbitofrontal cortex in the subjects with late-stage AD compared to that in normal subjects.